FDA Inspection 1218367 — Dr. Bruce G. Rankin, DO

Dr. Bruce G. Rankin, DO — FEI 3006528394

The FDA completed an inspection of Dr. Bruce G. Rankin, DO on September 22, 2023 in Deland, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 22, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Deland, FL (United States)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance